Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pharmaceutical CDMO Services market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pharmaceutical CDMO Servicesmarket, defines the market attractiveness level of Pharmaceutical CDMO Services market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pharmaceutical CDMO Services industry, describes the types of Pharmaceutical CDMO Services market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharmaceutical CDMO Services market and the development prospects and opportunities of Pharmaceutical CDMO Services industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharmaceutical CDMO Services market in Chapter 13.
By Player:
FAMAR Health Care Services
Eurofins CDMO
Catalent
Siegfried
Patheon
AMRI
WuXi AppTec Group
Piramal Pharma Solutions
Boehringer Ingelheim
Fareva
Aenova
Recipharm AB
Lonza
By Type:
Active Pharmaceutical Ingredient (API) Manufacturing
Finished Dosage Formulation (FDF) Development & Manufacturing
Secondary Packaging
By End-User:
Pre-clinical
Phase I
Phase II
Phase III
Phase IV
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pharmaceutical CDMO Services Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pharmaceutical CDMO Services Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pharmaceutical CDMO Services Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pharmaceutical CDMO Services Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pharmaceutical CDMO Services Market Analysis and Outlook to 2022
-
7.1 Global Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.2 United States Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.3 Europe Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.4 China Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.5 Japan Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.6 India Pharmaceutical CDMO Services Consumption (2017-2022)
-
7.7 South Korea Pharmaceutical CDMO Services Consumption (2017-2022)
8 Region and Country-wise Pharmaceutical CDMO Services Market Analysis and Outlook to 2028
-
8.1 Global Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.2 United States Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.3 Europe Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.4 China Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.5 Japan Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.6 India Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
-
8.7 South Korea Pharmaceutical CDMO Services Consumption Forecast (2022-2028)
9 Global Pharmaceutical CDMO Services Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmaceutical CDMO Services Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Active Pharmaceutical Ingredient (API) Manufacturing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Finished Dosage Formulation (FDF) Development & Manufacturing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Secondary Packaging Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmaceutical CDMO Services Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pre-clinical Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Phase I Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Phase II Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Phase III Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Phase IV Consumption and Growth Rate (2017-2022)
10 Global Pharmaceutical CDMO Services Market Outlook by Types and Applications to 2028
-
10.1 Global Pharmaceutical CDMO Services Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Active Pharmaceutical Ingredient (API) Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Finished Dosage Formulation (FDF) Development & Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Secondary Packaging Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pharmaceutical CDMO Services Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pre-clinical Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Phase I Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Phase II Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Phase III Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Phase IV Consumption Forecast and Growth Rate (2022-2028)
11 Global Pharmaceutical CDMO Services Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pharmaceutical CDMO Services Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pharmaceutical CDMO Services Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pharmaceutical CDMO Services Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pharmaceutical CDMO Services Market Competitive Analysis
-
14.1 FAMAR Health Care Services
-
14.1.1 FAMAR Health Care Services Company Details
-
14.1.2 FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 FAMAR Health Care Services Pharmaceutical CDMO Services Product and Service
-
14.2 Eurofins CDMO
-
14.2.1 Eurofins CDMO Company Details
-
14.2.2 Eurofins CDMO Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eurofins CDMO Pharmaceutical CDMO Services Product and Service
-
14.3 Catalent
-
14.3.1 Catalent Company Details
-
14.3.2 Catalent Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Catalent Pharmaceutical CDMO Services Product and Service
-
14.4 Siegfried
-
14.4.1 Siegfried Company Details
-
14.4.2 Siegfried Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Siegfried Pharmaceutical CDMO Services Product and Service
-
14.5 Patheon
-
14.5.1 Patheon Company Details
-
14.5.2 Patheon Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Patheon Pharmaceutical CDMO Services Product and Service
-
14.6 AMRI
-
14.6.1 AMRI Company Details
-
14.6.2 AMRI Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AMRI Pharmaceutical CDMO Services Product and Service
-
14.7 WuXi AppTec Group
-
14.7.1 WuXi AppTec Group Company Details
-
14.7.2 WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Product and Service
-
14.8 Piramal Pharma Solutions
-
14.8.1 Piramal Pharma Solutions Company Details
-
14.8.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Service
-
14.9 Boehringer Ingelheim
-
14.9.1 Boehringer Ingelheim Company Details
-
14.9.2 Boehringer Ingelheim Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Boehringer Ingelheim Pharmaceutical CDMO Services Product and Service
-
14.10 Fareva
-
14.10.1 Fareva Company Details
-
14.10.2 Fareva Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Fareva Pharmaceutical CDMO Services Product and Service
-
14.11 Aenova
-
14.11.1 Aenova Company Details
-
14.11.2 Aenova Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Aenova Pharmaceutical CDMO Services Product and Service
-
14.12 Recipharm AB
-
14.12.1 Recipharm AB Company Details
-
14.12.2 Recipharm AB Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Recipharm AB Pharmaceutical CDMO Services Product and Service
-
14.13 Lonza
-
14.13.1 Lonza Company Details
-
14.13.2 Lonza Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Lonza Pharmaceutical CDMO Services Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pharmaceutical CDMO Services
-
Figure Pharmaceutical CDMO Services Picture
-
Table Global Pharmaceutical CDMO Services Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharmaceutical CDMO Services Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharmaceutical CDMO Services Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pharmaceutical CDMO Services Consumption by Country (2017-2022)
-
Figure United States Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Figure China Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Figure India Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmaceutical CDMO Services Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical CDMO Services Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmaceutical CDMO Services Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Global Finished Dosage Formulation (FDF) Development & Manufacturing Consumption and Growth Rate (2017-2022)
-
Figure Global Secondary Packaging Consumption and Growth Rate (2017-2022)
-
Figure Global Pre-clinical Consumption and Growth Rate (2017-2022)
-
Figure Global Phase I Consumption and Growth Rate (2017-2022)
-
Figure Global Phase II Consumption and Growth Rate (2017-2022)
-
Figure Global Phase III Consumption and Growth Rate (2017-2022)
-
Figure Global Phase IV Consumption and Growth Rate (2017-2022)
-
Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Finished Dosage Formulation (FDF) Development & Manufacturing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Secondary Packaging Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pre-clinical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase III Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phase IV Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pharmaceutical CDMO Services Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pharmaceutical CDMO Services Export by Region (Top 5 Countries) (2017-2028)
-
Table FAMAR Health Care Services (Foundation Year, Company Profile and etc.)
-
Table FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table FAMAR Health Care Services Pharmaceutical CDMO Services Product and Service
-
Table Eurofins CDMO (Foundation Year, Company Profile and etc.)
-
Table Eurofins CDMO Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins CDMO Pharmaceutical CDMO Services Product and Service
-
Table Catalent (Foundation Year, Company Profile and etc.)
-
Table Catalent Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Pharmaceutical CDMO Services Product and Service
-
Table Siegfried (Foundation Year, Company Profile and etc.)
-
Table Siegfried Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siegfried Pharmaceutical CDMO Services Product and Service
-
Table Patheon (Foundation Year, Company Profile and etc.)
-
Table Patheon Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Patheon Pharmaceutical CDMO Services Product and Service
-
Table AMRI (Foundation Year, Company Profile and etc.)
-
Table AMRI Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table AMRI Pharmaceutical CDMO Services Product and Service
-
Table WuXi AppTec Group (Foundation Year, Company Profile and etc.)
-
Table WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table WuXi AppTec Group Pharmaceutical CDMO Services Product and Service
-
Table Piramal Pharma Solutions (Foundation Year, Company Profile and etc.)
-
Table Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Pharmaceutical CDMO Services Product and Service
-
Table Fareva (Foundation Year, Company Profile and etc.)
-
Table Fareva Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fareva Pharmaceutical CDMO Services Product and Service
-
Table Aenova (Foundation Year, Company Profile and etc.)
-
Table Aenova Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aenova Pharmaceutical CDMO Services Product and Service
-
Table Recipharm AB (Foundation Year, Company Profile and etc.)
-
Table Recipharm AB Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Recipharm AB Pharmaceutical CDMO Services Product and Service
-
Table Lonza (Foundation Year, Company Profile and etc.)
-
Table Lonza Pharmaceutical CDMO Services Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Pharmaceutical CDMO Services Product and Service
-
